EBOS Group Limited (ASX:EBO – Get Free Report) insider Mark Bloom bought 1,500 shares of the company’s stock in a transaction that occurred on Tuesday, October 21st. The shares were bought at an average price of A$25.10 per share, for a total transaction of A$37,647.00.
EBOS Group Stock Performance
The company has a debt-to-equity ratio of 66.89, a quick ratio of 0.76 and a current ratio of 0.95. The stock has a market cap of $8.20 billion, a PE ratio of 27.51 and a beta of 0.26.
EBOS Group Cuts Dividend
The business also recently announced a Final dividend, which was paid on Tuesday, September 23rd. Investors of record on Tuesday, September 23rd were given a dividend of $0.492 per share. This represents a dividend yield of 168.0%. The ex-dividend date was Wednesday, September 3rd. EBOS Group’s payout ratio is presently 72.14%.
EBOS Group Company Profile
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.
Featured Stories
- Five stocks we like better than EBOS Group
- Differences Between Momentum Investing and Long Term Investing
- The Drone Arms Race: From Battlefield to Balance Sheet
- How to trade using analyst ratings
- Why Wall Street Is Backing These 3 Comeback Stocks
- How to Use the MarketBeat Dividend Calculator
- Intel’s Breakout Quarter: More Than a Beat, It’s a Declaration
Receive News & Ratings for EBOS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EBOS Group and related companies with MarketBeat.com's FREE daily email newsletter.
